[
  {
    "ts": null,
    "headline": "Pfizer (PFE) CEO Isn’t Ready For A Fight With RFK Jr., Says Jim Cramer",
    "summary": "We recently published 10 Stocks Jim Cramer Talked About. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer talked about. Pharma giant Pfizer Inc. (NYSE:PFE)’s shares are down by 4.7% over the past year and flat year-to-date. UBS initiated coverage of the stock in January as it set a Neutral rating for the […]",
    "url": "https://finnhub.io/api/news?id=6686d91a2fb69a4fe82740e1a8956fa9861308ef894a36f2e40aed6bc48e7717",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768585594,
      "headline": "Pfizer (PFE) CEO Isn’t Ready For A Fight With RFK Jr., Says Jim Cramer",
      "id": 138154095,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published 10 Stocks Jim Cramer Talked About. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer talked about. Pharma giant Pfizer Inc. (NYSE:PFE)’s shares are down by 4.7% over the past year and flat year-to-date. UBS initiated coverage of the stock in January as it set a Neutral rating for the […]",
      "url": "https://finnhub.io/api/news?id=6686d91a2fb69a4fe82740e1a8956fa9861308ef894a36f2e40aed6bc48e7717"
    }
  },
  {
    "ts": null,
    "headline": "Trump’s New Prescription Plan vs. Mark Cuban’s: Experts Weigh In",
    "summary": "Fed up with soaring prescription drug costs, billionaire Mark Cuban launched the Mark Cuban CostPlus Drug Company, an online pharmacy offering low-cost generic medications, with co-founder Alex...",
    "url": "https://finnhub.io/api/news?id=979f36c7df29fb17489890c9e2296ec3d4ca920b289a7bee24012f68dfc68811",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768577329,
      "headline": "Trump’s New Prescription Plan vs. Mark Cuban’s: Experts Weigh In",
      "id": 138152502,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Fed up with soaring prescription drug costs, billionaire Mark Cuban launched the Mark Cuban CostPlus Drug Company, an online pharmacy offering low-cost generic medications, with co-founder Alex...",
      "url": "https://finnhub.io/api/news?id=979f36c7df29fb17489890c9e2296ec3d4ca920b289a7bee24012f68dfc68811"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Rebound Has Just Started",
    "summary": "Pfizer: Rebound Has Just Started",
    "url": "https://finnhub.io/api/news?id=e9efe5e2c354b1e2b35f274d0726ed1178923d71b30ceccbfb4b0e84e66b3839",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768568883,
      "headline": "Pfizer: Rebound Has Just Started",
      "id": 138154296,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e9efe5e2c354b1e2b35f274d0726ed1178923d71b30ceccbfb4b0e84e66b3839"
    }
  },
  {
    "ts": null,
    "headline": "Stocks With Juicy Dividends Are Tempting. But How Risky Are They?",
    "summary": "If the dividend yield exceeds the bond yield, it’s a sign that bond investors are comfortable with a company’s creditworthiness and that the dividend is relatively safe.",
    "url": "https://finnhub.io/api/news?id=2c4c001bab8e3e1b424e830143e892c5628b9c5c14181ca439a6afa37389cf0b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768546800,
      "headline": "Stocks With Juicy Dividends Are Tempting. But How Risky Are They?",
      "id": 138149619,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "If the dividend yield exceeds the bond yield, it’s a sign that bond investors are comfortable with a company’s creditworthiness and that the dividend is relatively safe.",
      "url": "https://finnhub.io/api/news?id=2c4c001bab8e3e1b424e830143e892c5628b9c5c14181ca439a6afa37389cf0b"
    }
  },
  {
    "ts": null,
    "headline": "1 Healthcare Stock Worth Your Attention and 2 We Avoid",
    "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 21.1% over the past six months, topping the S&P 500 by 10.6 percentage points.",
    "url": "https://finnhub.io/api/news?id=502761ee02508c3007fcb5016c636face0dc84d44571643df6f0f0ca26eb0827",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768538186,
      "headline": "1 Healthcare Stock Worth Your Attention and 2 We Avoid",
      "id": 138152615,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 21.1% over the past six months, topping the S&P 500 by 10.6 percentage points.",
      "url": "https://finnhub.io/api/news?id=502761ee02508c3007fcb5016c636face0dc84d44571643df6f0f0ca26eb0827"
    }
  }
]